<DOC>
	<DOCNO>NCT01229007</DOCNO>
	<brief_summary>The objective study assess efficacy safety Von Willebrand Factor/Factor VIII ( VWF/FVIII ) , Biostate , investigate pharmacokinetics Biostate child haemophilia A .</brief_summary>
	<brief_title>Study Biostate® Children With Hemophilia A</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Male subject 0 &lt; 12 year age . Diagnosed severe haemophilia A ( FVIII : C &lt; 1 % ) , pretreated minimum 20 50 exposure day . Have evidence vaccination hepatitis A B ( presence antibody hepatitis A B due either previous infection prior immunisation ) , document medical note enrolment . The subject and/or legal guardian understand ( ) nature study has/have give write informed consent participate study is/are willing comply protocol . For subject Day 1 : Are actively bleed . Have receive infusion FVIII product , cryoprecipitate , whole blood , plasma desmopressin acetate 4 day prior dose within PK component . Have know history , suspect FVIII inhibitor . Have receive aspirin nonsteroidal antiinflammatory drug ( NSAIDs ) within 7 day administration IMP . Have impair liver function ie , bilirubin &gt; 1.5 x upper limit normal ( ULN ) and/or aspartate/alanine aminotransferase ( AST/ALT ) &gt; 2.5 x ULN ( refer limit laboratory performs determination ) Screening . Are human immunodeficiency virus [ HIV ] 1/2 antibody positive viral load &gt; 200/µL . Suffer acute chronic medical condition , haemophilia A , may , opinion Investigator , affect conduct study . Suffering von Willebrand disease ( VWD ) von Willebrand factor : ristocetin cofactor ( VWF : RCo ) level &lt; 50 IU/dL Screening . Have know suspect hypersensitivity previous evidence severe side effect plasmaderived FVIII product human albumin . Have participate clinical study use investigational compound another study ( eg , new chemical entity register clinical use ) 3 month precede first day IMP administration , plan enter study study period . Unwillingness and/or inability comply study requirement .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Hemophilia A</keyword>
	<keyword>Children</keyword>
</DOC>